U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07422428) titled 'Overlooked Barrier To Discontinuing Bont-A Therapy' on Jan. 27.
Brief Summary: This study aims to evaluate patient adherence to botulinum toxin (BoNT-A) treatment and identify the factors contributing to its discontinuation.
This retrospective cohort study analyzed the medical records of patients who received at least one botulinum toxin treatment for post-stroke spasticity (PSS) from 2012 to 2024. Eighty-one enrolled patients responded to structured questions about their reasons for not consistently continuing BoNT-A treatment.
Study Start Date: Sept. 23, 2024
Study Type: OBSERVATIONAL
Condition:
Post Stroke Spastic Hemiplegia...